by B2i | Aug 13, 2020 | Press Releases
Entered into two new collaborations with top tier animal health companies Entered into a fully funded human health collaboration with a top five global pharmaceutical company Started an animal trial for SARS-CoV-2 RBD vaccine candidate in Israel and another animal...
by B2i | Jul 30, 2020 | Press Releases
JUPITER, FL / July 30, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower production costs and improve...
by B2i | Jul 15, 2020 | Press Releases
JUPITER, FL / July 15, 2020 / Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary...
by B2i | Jul 8, 2020 | Press Releases
Dyadic Now Partnered with all of the Top Four Animal Health Companies Five Fully Funded Animal Health Research Projects with Three New Relationships Announced this Year JUPITER, FL / July 8, 2020 / Dyadic International, Inc. (“Dyadic”, “we”,...
by B2i | Jun 29, 2020 | Press Releases
JUPITER, FL / June 29, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and...
by B2i | Jun 10, 2020 | Press Releases
JUPITER, FL / June 10, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development,...
